Tempus AI, Inc. (TEM)
66.75
+2.41
(+3.75%)
USD |
NASDAQ |
Oct 20, 16:00
67.17
+0.42
(+0.63%)
After-Hours: 07:25
Tempus AI Research and Development Expense (TTM) : 364.39M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 364.39M |
| March 31, 2026 | 343.92M |
| December 31, 2025 | 319.03M |
| September 30, 2025 | 289.89M |
| June 30, 2025 | 264.87M |
| March 31, 2025 | 334.70M |
| December 31, 2024 | 316.84M |
| September 30, 2024 | 304.11M |
| Date | Value |
|---|---|
| June 30, 2024 | 293.48M |
| March 31, 2024 | 193.14M |
| December 31, 2023 | 185.50M |
| September 30, 2023 | 179.19M |
| June 30, 2023 | 168.09M |
| March 31, 2023 | 154.47M |
| December 31, 2022 | 136.88M |
| December 31, 2021 | 118.02M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Personalis, Inc. | 56.12M |
| 10X Genomics, Inc. | 226.80M |
| Twist Bioscience Corp. | 71.86M |
| Moderna, Inc. | 2.635B |
| IQVIA Holdings, Inc. | -- |